Using Diagnostic Tools for the Management of Uterine Fibroids
Mauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, comment on the use of diagnostic tools and the importance of imaging in approaching the treatment of uterine fibroids.
EP: 1.Overview of Uterine Fibroids
EP: 2.Using Diagnostic Tools for the Management of Uterine Fibroids
EP: 3.Goals of Therapy for Uterine Fibroids
EP: 4.Considerations for Surgical Options for Treating Uterine Fibroids
EP: 5.Approaching the Medical Management of Uterine Fibroids
EP: 6.Role of GnRH Antagonists for Uterine Fibroid Management
EP: 7.Safety and Efficacy of GnRH Antagonists in Uterine Fibroid Treatment
EP: 8.Treatment Selection of GnRH Antagonists for Uterine Fibroids
EP: 9.Unmet Needs in the Management of Uterine Fibroids
Mauricio Abrão, MD: For us to discuss details about the treatment options, it’s important to talk about imaging for the diagnosis of fibroids, because the decision on how to treat starts from a good diagnosis. We’ve had great improvements of the ultrasound and MRI. What do you think about what we have now, Jessica?
Jessica A. Shepherd, MD, MBA, FACOG: As far as treatment goals and looking at imaging, I always send every patient for an ultrasound. I love when they come from a family practitioner or an internal medicine physician who sends them with an ultrasound. That’s very helpful. In past years in my practice, I’ve seen that MRI has had a good impact on helping them understand and see, and also come up with a treatment-management plan. There are definitely patients who have had an ultrasound for something else, maybe a GI [gastrointestinal] issue, where fibroids are noted on the ultrasound or MRI. How do we use that imaging and information to help guide patients who may have had asymptomatic fibroids and now know that they have fibroids?
With patients who have symptomatic issues with their fibroids, how do we make sure they understand the depth and breadth of the disease process and what treatment options are available for them from an imaging standpoint? Because quite frankly, I find that when patients see it on imaging, that puts them into another realm of fear to some degree. How do we mitigate that? How do we allow them to see that the imaging is very helpful for a physician but can actually help us more when it comes to a plan of medical or surgical management or a combination of both?
Mauricio Abrão, MD: I agree. One very relevant thing is that there are new protocols for us to differentiate fibroids from sarcoma by imaging, mainly by MRI, for example. This is important for us to define the treatment. The improvement of the imaging is something to be mentioned in a discussion like this because of its beneficial impact on treatment.
Transcript Edited for Clarity
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More
Pap Talk S4E4: RFA and uterine fibroids with Dr. Jessica Shepherd
March 30th 2022In this episode of Pap Talk, Jessica Shepherd, MD, MBA, FACOG, deep dives into the benefits of utilizing radio frequency ablation (RFA) for treatment of uterine fibroids, available RFA devices, and disparities in the condition.
Listen
Study finds relugolix-CT Improves HMB in Black women
February 19th 2024Recent research highlights the efficacy and safety of relugolix combination therapy in managing uterine fibroid-associated heavy menstrual bleeding specifically among Black women, demonstrating outcomes comparable to the broader population.
Read More
Physician-patient collaboration for uterine fibroid treatment options
May 12th 2021Contemporary OB/GYN®’s senior editor Angie DeRosa sat down with Ayman Al-Hendy, MD, and Sateria Venable of The Fibroid Foundation, to discuss the role of patient-physician collaboration in uterine fibroid treatment and management options.
Listen
